Article info
PDFCurrent controversy
Reassessing the VaxTax
- Correspondence to Nathan Petrovic, Philosophy, Université de Genève, Geneve, Switzerland; petrovic.nathan1998{at}gmail.com
Citation
Reassessing the VaxTax
Publication history
- Received March 2, 2023
- Accepted August 12, 2023
- First published September 6, 2023.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Other content recommended for you
- Vaccine equity in COVID-19: a meta-narrative review
- It is not too late to achieve global covid-19 vaccine equity
- Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries
- ‘VaxTax’: a follow-up proposal for a global vaccine pandemic response fund
- Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis
- Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access
- Analysis of the institutional landscape and proliferation of proposals for global vaccine equity for COVID-19: too many cooks or too many recipes?
- Vaccines, therapeutics, and diagnostics for covid-19: redesigning systems to improve pandemic response
- Incentivising wealthy nations to participate in the COVID-19 Vaccine Global Access Facility (COVAX): a game theory perspective
- Why are vaccination rates lower in low and middle income countries, and what can we do about it?